High-fat- and lipid-induced insulin resistance in rats: The comparison of glucose metabolism, plasma resistin and adiponectin levels

Annals of Nutrition and Metabolism

Volumn 50, Issue 6, 2007, Pages 499-505

  Li, Ling ^a   Yang, Gangyi ^a   Li, Qingming ^a   Tang, Yi ^a   Li, Ke ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Fat, high; High fat resitin; Insulin resistance; Lipid

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FAT; FATTY ACID; LIPID; LIPID EMULSION; RESISTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; HORMONE ACTION; INSULIN RESISTANCE; LIPID DIET; LIVER; MALE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SKELETAL MUSCLE; STEADY STATE;

ADIPONECTIN; ADMINISTRATION, ORAL; ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; HYPERLIPIDEMIAS; INFUSIONS, INTRAVENOUS; INSULIN RESISTANCE; LIVER; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN;

ANIMALIA; RATTUS;

EID: 33846865810     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098141     Document Type: Article

References (33)

1. DeFronzo RA: The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
2. Reaven GM, Hollenbeck C, Jengk C-Y, Wu MS, Chen Y-D: Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 hours in patients with NIDDM. Diabetes 1988;37:1020-1024.
3. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3-10.
4. Chakley SM, Hettiarachchi M, Chisholm DJ, Kraegen EW: Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rats. Metabolism 1998;47:1121-1126.
5. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanism of fatty acid induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-2446.
6. Hevener AL, Reichart D, Janez A, Olefsky J: Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male Wistar rats. Diabetes 2001;50:2316-2322.
7. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992;15:318-326.
8. Kim CH, Kim MS, Youn JY, Park HS, Song HS, Song KH, Park JY, Lee K-U: Lipolysis in skeletal muscle is decreased in high-fat-fed rats. Metabolism 2003;52:1586-1592.
9. Xinhua C, Iqbal N, Boden G: The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 1999;103:365-372.
10. Nolte LA, Galuska D, Martin IK, Zierath JR, Wallberg-Henriksson H: Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle. Acta Physiol Scand 1994;151:51-59.
11. Roden M, Price TB, Perseghin G, Falk-Peterson K, Rothman D, Cline GW, Shulman GI: Mechanisms of free fatty-acid induced insulin resistance in humans. J Clin Invest 1996;97:2859-2865.
12. Muse ED, Obicil S, Bhanot S, Monia, BP, McKay RA, Rajala MW, Scherer PE, Rossetti L: Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004;114:232-239.
13. Ye JM, Dzamko N, Cleasby ME, Hegarty BD, Furler SM, Cooney GJ, Kraegen EW: Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevent fatty-acid-induced insulin resistance in the rat: comparison with metformin. Diabetologia 2004;47:1306-1313.
14. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI: Free fatty-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999;48:1270-1274.
15. Rigalleau V, Beylot M, Pachiaudi C, Guillot C, Deleris G, Gin H: Mechanisms of glucose intolerance during triglyceride infusion. Am J Physiol 1998;275:E641-E648.
16. Koshinaka K, Oshida Y, Han Y-Q, Kuboda M, Viana AYI, Nagasaki M, Sato Y: Insulin-nonspecfic reduction in skeletal muscle glucose transport in high-fat-fed rats. Metabolism 2004;53:912-917.
17. Kershaw EE, Flier FS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
18. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al: PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099.
19. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
20. Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Miki H, et al: Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest 2001;108:1001-1013.
21. Cheung P, Yang G, Boden G: Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion. Metabolism 2003;52:1496-1500.
22. Li L, Yang GY: Effect of hepatic glucose production on acute insulin resistance induced by lipid-infusion in awake rats. World J Gastroenterol 2004;10:3208-3211.
23. Steele R, Wall JS, DeBodo RC: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956;187:15-24.
24. Kelley DE, Goodpaster B, Wing RR, Simoneau JA: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130-E1141.
25. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, Biden TJ: Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of high fat-fed rat. Diabetes 1997;46:169-178.
26. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW: Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 1997;46:1768-1774.
27. Nakahara I, Matsuhisa M, Shiba Y, Kuroda A, Nakatani Y, Hatazaki M, et al: Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats. Diabetes Res Clin Pract 2004;66:109-118.
28. Rajala MW, Obici S, Scherer PE, Rossetti L: Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 2003;111:225-230.
29. Satoh H, Nguyen MTA, Miles PDG, Imamura T, Usui I, Olefsky JM: Adenovirus-mediated chronic 'hyper-resistinemia' leads to in vivo insulin resistance in normal rats. J Clin Invest 2004;114:224-231.
30. Li C, Nyomba BL: Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet. Endocrinology 2003;44:500-508.
31. Weyer C, Funahashi T, Tanaka S, Hotta K, Kubota N, Hara K, et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
32. Mary Y, Nikos Y, Susann B, Antonia-Leda M, Dorothy KZ, Christos SM: Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003;88:1730-1736.
33. Tschritte O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al: Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-243.